NOEMI MANCEÑIDO MARCOS

Profesor colaborador del Grado de Medicina

Universidad Autónoma de Madrid

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Noemi Manceñido Marcos is a Professor Collaborator in the Medicine Degree Program at Universidad Europea de Madrid, Spain. Her research primarily focuses on inflammatory bowel disease, with recent articles investigating the efficacy and safety of biologics, drug monitoring strategies, and the impact of COVID-19 on patients with immunomediated inflammatory diseases. She also explores factors affecting immigrant patients and the effects of dietary components on colitis.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Henit Yanai

ISRAEL

NOEMI MANCEÑIDO MARCOS

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Efficacy and safety of proactive drug monitoring in inflammatory bowel disease treated with anti-TNF agents: A systematic review and meta-analysis

Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

Incidence of COVID-19 in 902 Patients with Immunomediated Inflammatory Diseases Treated with Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs - Findings from the BIOCOVID Study

Polyphenols and Ulcerative Colitis: An Exploratory Study of the Effects of Red Wine Consumption on Gut and Oral Microbiome in Active-Phase Patients

Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study

Collaborators (15)

Henit Yanai

Glen Doherty

Pär Myrelid

Manuel Barreiro de Acosta

ALEJANDRO HERNANDEZ CAMBA

Jose Luis Cabriada

Jose M. Arbones-Mainar

Triana Lobaton Ortega

MARIA ESTEVE

Luis Fernández-Salazar

Ann-Sofie Backman

Ingrid Ordas

Fernando Gomollón

Mette Julsgaard

María Chaparro

Make your next move.